Sleep-dependent Negative Overgeneralization in Adolescent Anxiety
Project Number2R01MH116005-06
Former Number3R01MH116005-05
Contact PI/Project LeaderMATTFELD, AARON Other PIs
Awardee OrganizationFLORIDA INTERNATIONAL UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY
Sleep is essential to our well-being, yet sleep problems are pervasive across mental health disorders and are
heightened during adolescence – a developmental window of notable biological and social changes coinciding
with escalations of anxiety disorders and depression. Consistent with the NIMH strategic plan, we aim to map
the longitudinal course of sleep neurophysiology, brain maturation, emotion reactivity, and memory
generalization and their relation to emotional health from the onset of adolescence through mid-late
adolescence to inform novel treatments and minimize emotional health risks during this critical developmental
window. In our ongoing R01, we have focused on mechanisms related to negative overgeneralization – a core
dimension of anxiety that is poorly understood. We have found that sleep fails to depotentiate the response of
the amygdala to negative stimuli in participants with elevated anxiety and negative overgeneralization emerges
from an interplay between the amygdala at encoding and pattern completion supported by activity in the CA1
subfield of the hippocampus during retrieval. This proposal builds on and extends our ongoing R01 by
longitudinally following the same individuals to investigate our hypothesis that altered emotional reactivity,
sleep neurophysiology, and overgeneralization of negative memories arise from an imbalance between the
amygdala and the hippocampus. Further, we posit that the amygdalo-hippocampal imbalance, exacerbated by
the emotional and social changes prevalent during adolescence, contributes to the escalation of internalizing
symptom severity often noted during this developmental window. The current renewal proposal tests this
model using an accelerated longitudinal approach combining multiple methods – detailed clinical assessment,
neuroimaging, polysomnography, and emotional memory task – across three time points, collected every ~18
months, in each participant to examine longitudinal maturation from peri-adolescence through mid-late
adolescence. Youth (retained: n=140; newly recruited: n=80; total: N=220) across a continuum of anxiety
symptoms, assigned to one of four cohorts based on their age at baseline will be enrolled in the proposed
renewal study. Aim 1 will utilize the nocturnal polysomnography and structural and functional neuroimaging
data collected at baseline and the two follow-up sessions to evaluate the longitudinal relation between
amygdalo-hippocampal function and changes in sleep. Aim 2 will focus on behavior from the emotional
memory task and functional neuroimaging data collected across waves to evaluate the longitudinal relation
between amygdalo-hippocampal function and changes in negative overgeneralization. Aim 3 will incorporate
the detailed clinical assessments collected across waves to investigate the longitudinal relation between
amygdalo-hippocampal function, sleep neurophysiology, negative overgeneralization, and internalizing
symptom severity. This project will provide critically needed data to advance mechanistic understanding of how
sleep and neuromaturation influence emotional health in this sensitive period.
Public Health Relevance Statement
PROJECT NARRATIVE
The current proposal focuses on the escalation of anxiety severity across adolescence and aims to elucidate a
developmental mechanism rooted in the functional balance between the amygdala and hippocampus. We
propose a developmental model for how altered amygdalo-hippocampal function in early adolescence
contributes to heightened emotional reactivity, disturbed sleep neurophysiology, and the overgeneralization of
negative memories, which in turn leads to the rise of internalizing symptom severity in mid-late adolescence.
Support for our model would suggest that the functional balance between key brain structures in sensitive
developmental periods are central to the course and severity of anxiety and related disorders and may point to
novel biomarkers and interventions.
No Sub Projects information available for 2R01MH116005-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01MH116005-06
Patents
No Patents information available for 2R01MH116005-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01MH116005-06
Clinical Studies
No Clinical Studies information available for 2R01MH116005-06
News and More
Related News Releases
No news release information available for 2R01MH116005-06
History
No Historical information available for 2R01MH116005-06
Similar Projects
No Similar Projects information available for 2R01MH116005-06